Embolotherapy Market is Set to Reach USD 4,984.7 million by 2024

The global embolotherapy market is expected to grow at a CAGR of 7.7% during the forecast period with its market size predicted to reach USD 4,984.7 million by 2024.

Request for Sample Copy at https://www.vynzresearch.com/healthcare/embolotherapy-market/request-sample

Based on end user, the global embolotherapy market is segmented into ambulatory surgical centers (ASCs), hospitals and clinics, and others.

North America has accounted for the largest share in embolotherapy market, globally and is predicted to grow significantly during the forecast period, owing to the increasing emphasis in the region towards development of advanced embolic agents, extensive pervasiveness of incidents that necessitates adoption of embolization processes.

Some of the players having prominent presence in the global embolotherapy market include Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.

Source: VynZ Research